Synthesis and evaluation of novel fused pyrimidine derivatives as GPR119 agonists

Wacker, 2014, Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an antidiabetic clinical candidate targeting GPR119, J. Med. Chem., 57, 7499, 10.1021/jm501175v Scott, 2014, Circumventing seizure activity in a series of G protein coupled receptor 119 (GPR119) agonists, J. Med. Chem., 57, 8984, 10.1021/jm5011012 Jang, 2017, Design, synthesis, and biological evaluation of aryl N-methoxyamide derivatives as GPR119 agonists, Bioorg. Med. Chem. Lett., 27, 3909, 10.1016/j.bmcl.2017.06.032 Overton, 2010, GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity, Br. J. Pharmacol., 153, S76, 10.1038/sj.bjp.0707529 Jones, 2009, Chapter 7 The Emergence of GPR119 Agonists as Anti-Diabetic Agents, Annu. Rep. Med. Chem., 44, 149 Hansen, 2012, GPR119 as a fat sensor, Trends Pharmacol. Sci., 33, 374, 10.1016/j.tips.2012.03.014 Harada, 2018, Design and synthesis of novel and potent GPR119 agonists with a spirocyclic structure, Bioorg. Med. Chem. Lett., 28, 1228, 10.1016/j.bmcl.2018.02.044 Zhu, 2017, Discovery of phenyl acetamides as potent and selective GPR119 agonists, Bioorg. Med. Chem. Lett., 27, 1124, 10.1016/j.bmcl.2017.01.091 Semple, 2008, Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119, J. Med. Chem., 51, 5172, 10.1021/jm8006867 Matsuda, 2018, Design synthesis and biological evaluation of novel 7-azaspiro[3.5]nonane derivatives as GPR119 agonists, Bioorg. Med. Chem., 26, 1832, 10.1016/j.bmc.2018.02.032 Fang, 2015, Recent progress in GPR119 agonists for type 2 diabetes, Chin. J. New Drugs., 24, 2695 Yang, 2013, Synthesis and biological evaluation of 5-nitropyrimidine analogs with azabicyclic substituents as GPR119 agonists, Bioorg. Med. Chem. Lett., 23, 1519, 10.1016/j.bmcl.2012.12.011 Fang, 2017, Novel 5-nitropyrimidine derivatives bearing endo-azabicyclic alcohols/amines as potent GPR119 agonists, Bioorg. Med. Chem., 25, 254, 10.1016/j.bmc.2016.10.030 Yang, 2017, Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist, Bioorg. Med. Chem. Lett., 27, 2515, 10.1016/j.bmcl.2017.03.092 Boelsterli, 2006, Bioactivation and hepatotoxicity of nitroaromatic, drugs Curr, Drug Metab., 7, 715, 10.2174/138920006778520606 Paraskevopoulos, 2015, Novel derivatives of nitro-substituted salicylic acids: synthesis, antimicrobial activity and cytotoxicity, Bioorg. Med. Chem., 23, 7292, 10.1016/j.bmc.2015.10.029 Pham, 2013, Synthesis and biological evaluation of novel 2,4-disubstituted quinazoline analogues as GPR119 agonists, Bioorg. Med. Chem., 21, 1349, 10.1016/j.bmc.2012.12.013 Wang, 2008, L-Proline-Promoted Rosenmund-von Braun Reaction, Synlett., 2008, 69, 10.1055/s-2007-992409 Zhu, 2005, Synthesis of Aryl Sulfones via L-Proline-Promoted CuI-Catalyzed Coupling Reaction of Aryl Halides with Sulfinic Acid Salts, J. Org. Chem., 70, 2696, 10.1021/jo047758b Berdini, 2002, A modified palladium catalysed reductive amination procedure, Tetrahedron., 58, 5669, 10.1016/S0040-4020(02)00530-6 Fang, 2018, Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes, Bioorg. Med. Chem., 26, 4080, 10.1016/j.bmc.2018.06.035 Bogdan, 2011, Synthesis of 5-Iodo-1,2,3-triazole-Containing Macrocycles Using Copper Flow Reactor Technology, Org. Lett., 13, 4060, 10.1021/ol201567s S. Pierau, G. Dale, PCT 2006021448, 2006.